UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

A positive feedback loop of ER-α36 EGFR promotes malignant growth of ER-negative breast cancer cells

Oncogene, 2011-02, Vol.30 (7), p.770-780

2011

Volltextzugriff (PDF)

A positive feedback loop of ER- alpha 36/EGFR promotes malignant growth of ER-negative breast cancer cells

Oncogene, 2011-02, Vol.30 (7), p.770-780

2011

Volltextzugriff (PDF)

Spindle cell carcinoma of the breast: Rare cancer with potentially targetable biomarkers

Annals of oncology, 2019-05, Vol.30, p.iii19-iii19

2019

Volltextzugriff (PDF)

PD-1, PD-L1 expression in 1599 gynecological cancers: Implications for immunotherapy

Gynecologic oncology, 2015-04, Vol.137, p.204-205

2015

Volltextzugriff (PDF)

Paving the road to personalized medicine in cervical cancer: Theranostic biomarker evaluation in a 592-specimen library

Gynecologic oncology, 2015-04, Vol.137, p.141-141

2015

Volltextzugriff (PDF)

Microarray analysis of vascular endothelial growth factor (VEGF)-dependent angiogenic biomarkers in squamous cell carcinoma (SCCA) and adenocarcinoma (AC) of the cervix

Gynecologic oncology, 2015-04, Vol.137, p.140-141

2015

Volltextzugriff (PDF)

1PD Differences in expression of predictive biomarkers between primary and metastatic non-small cell lung cancer tumors

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S57-S57

2016

Volltextzugriff (PDF)

2771 BRCA1 and BRCA2 mutations in 1691 epithelial ovarian tumors identify subgroups with distinct molecular characteristics

European journal of cancer (1990), 2015-09, Vol.51, p.S554-S555

2015

Volltextzugriff (PDF)

Molecular Attributes of Metastatic Thyroid Cancers

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.948-948

2016

Volltextzugriff (PDF)

Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

Annals of oncology, 2018-06, Vol.29, p.v36-v36

2018

Volltextzugriff (PDF)

213 BRAF mutations are potentially targetable alterations in a wide variety of solid cancers

European journal of cancer (1990), 2015-09, Vol.51, p.S31-S31

2015

Volltextzugriff (PDF)

215 Using ALK IHC test to identify potential responders to ALK inhibitors outside of NSCLC

European journal of cancer (1990), 2015-09, Vol.51, p.S32-S32

2015

Volltextzugriff (PDF)

475 Differences in Gene Expression Between Androgen Receptor Positive and Negative Triple Negative (ER/PR/Her2) Breast Carcinomas

European journal of cancer (1990), 2012-11, Vol.48, p.147-147

2012

Volltextzugriff (PDF)

Biomarkers of immune therapy in CUP

Annals of oncology, 2017-09, Vol.28, p.v27-v27

2017

Volltextzugriff (PDF)

254 Multi-platform molecular profiling of 1,180 patients increases median overall survival and influences treatment decision in 53% of cases

European journal of cancer (1990), 2015-09, Vol.51, p.S44-S44

2015

Volltextzugriff (PDF)

Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial Virus-Infected Mice: Role of MIP-1α in Lung Pathology

Journal of Virology, 2001-01, Vol.75 (2), p.878-890

2001

Volltextzugriff (PDF)

948 Transcriptome Analysis and Theranostic Profiling of Ewing Sarcoma (ES) and Desmoplastic Small Round Cell Tumours (DSRCT)

European journal of cancer (1990), 2012-07, Vol.48, p.S228-S228

2012

Volltextzugriff (PDF)

65O HER2 IN NON-SMALL CELL LUNG CARCINOMAS

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S30-S30

2013

Volltextzugriff (PDF)

1057PMolecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

134PImmuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1057P - Molecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

Annals of oncology, 2019-10, Vol.30, p.v430-v431

2019

Volltextzugriff (PDF)

134P - Immuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

Annals of oncology, 2019-10, Vol.30, p.v42-v42

2019

Volltextzugriff (PDF)

Molecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

Annals of oncology, 2019-10, Vol.30, p.v430-v431

2019

Volltextzugriff (PDF)

Immuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

Annals of oncology, 2019-10, Vol.30, p.v42

2019

Volltextzugriff (PDF)

PD-L1 expression patterns in the metastatic tumors to the lung: A comparative study with the primary non-small cell lung cancer

Annals of oncology, 2017-04, Vol.28, p.ii52

2017

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Englisch
(184)
Japanisch
(15)
Croatian
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(61)
Female
(39)
Male
(36)
Immunohistochemistry
(29)
Biological And Medical Sciences
(27)
Middle Aged
(27)
Adult
(25)
Oncology
(24)
Aged
(23)
Medical Sciences
(23)
Pathology
(21)
Hematology, Oncology And Palliative Medicine
(13)
Tumors
(11)
Adolescent
(10)
Aged, 80 And Over
(10)
Cell Biology
(10)
Animals
(9)
Mutation
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A positive feedback loop of ER-α36 EGFR promotes malignant growth of ER-negative breast cancer cells

A positive feedback loop of ER- alpha 36/EGFR promotes malignant growth of ER-negative breast cancer cells

Spindle cell carcinoma of the breast: Rare cancer with potentially targetable biomarkers

PD-1, PD-L1 expression in 1599 gynecological cancers: Implications for immunotherapy

Paving the road to personalized medicine in cervical cancer: Theranostic biomarker evaluation in a 592-specimen library

Microarray analysis of vascular endothelial growth factor (VEGF)-dependent angiogenic biomarkers in squamous cell carcinoma (SCCA) and adenocarcinoma (AC) of the cervix

1PD Differences in expression of predictive biomarkers between primary and metastatic non-small cell lung cancer tumors

2771 BRCA1 and BRCA2 mutations in 1691 epithelial ovarian tumors identify subgroups with distinct molecular characteristics

Molecular Attributes of Metastatic Thyroid Cancers

Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

213 BRAF mutations are potentially targetable alterations in a wide variety of solid cancers

215 Using ALK IHC test to identify potential responders to ALK inhibitors outside of NSCLC

475 Differences in Gene Expression Between Androgen Receptor Positive and Negative Triple Negative (ER/PR/Her2) Breast Carcinomas

Biomarkers of immune therapy in CUP

254 Multi-platform molecular profiling of 1,180 patients increases median overall survival and influences treatment decision in 53% of cases

Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial Virus-Infected Mice: Role of MIP-1α in Lung Pathology

948 Transcriptome Analysis and Theranostic Profiling of Ewing Sarcoma (ES) and Desmoplastic Small Round Cell Tumours (DSRCT)

65O HER2 IN NON-SMALL CELL LUNG CARCINOMAS

1057PMolecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

134PImmuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

1057P - Molecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

134P - Immuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

Molecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix

Immuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas

PD-L1 expression patterns in the metastatic tumors to the lung: A comparative study with the primary non-small cell lung cancer

Suchergebnisse filtern